News

Increased respiratory viral testing for COVID-19 and Influenza could have contributed to improved antibiotic prescribing for respiratory symptoms.

Brain tissue in people who died of SARS-CoV-2 look suspiciously like that of people with various forms of dementia and other neurocognitive conditions.

With millions of people facing long-term COVID-19 conditions, the CDC issued interim guidance on evaluation and care.

The COVID-19 pandemic had a substantial effect on women in Kenya who are reliant on transactional sex for income, leading to high levels of food insecurity and psychological burden.

Even if HIV-positive individuals have a low-to-moderate risk for cardiovascular disease, they still experience more coronary plaque.

The activity was higher than what was recently observed for the South African variant.

94% of the participants in the study developed COVID-19 antibodies.

A new Australian study shows the infection rate was 1.61 cases per 1000 people per year over a 3 year study period in participants with access to the therapy.

A group of scientists who published a letter in a French newspaper asked for an inquiry to determine how the virus emerged.

The therapy, developed by Lupin Pharmaceuticals, now includes the treatment of trichomoniasis in adults patients and their partners.

At the highest dosage, PfSPZ conferred protection for 3 months.

Unvaccinated healthcare workers showed similar levels of antibodies to vaccinated ones.

COVID-19-associated hospitalization of adolescents is more than 12 times less likely than that of adults, but exceeds that associated with influenza by 2.5 to 3 times, the US Centers for Disease Control and Prevention (CDC) reported.

The therapy would be the first capsid inhibitor and the only HIV treatment option administered every 6 months.

The Food and Drug Administration (FDA) said the company is concerned about cyclospora contamination on the company’s Dole Fresh Blueberries brand.

A discussion about the Association for Professionals in Infection Control and Epidemiology with CEO Devin Jopp.

Screening and isolation protocols were shown to reduce the risk of transmission.

AFHs reported concerns such as staff coming to work sick and lack of PPE.

IPs experienced PPE shortages, high levels of stress and emotional exhaustion.

A study looked at the prevalence of Metallo-B-lactamase (MBLs) producing A. baumannii isolates in one hospital setting.

Staff trainings on prevention practices were found to be common by inconsistent.

This event will be a free, virtual event in July with expert speakers and survivors.

The organizations and their full-time employees both benefited from the PRN IPs.

The newly approved therapy will use the brand name, Brexafemme, and is a one-day, novel, oral treatment for vaginal yeast infection.

A significant decrease in the rate of VAP occurred during the study period.

Post-intervention saw 55% of patients receive overall guideline-concordant antibiotics.

Nonspecific, nondolent symptoms make this disease difficult to diagnose.

The Sinovac developed vaccine generated antibodies against SARS-CoV-2 in a phase 1/2 trial.

Sensors provided data for more hand washing opportunities for healthcare workers and affected related behaviors.

The CAD demonstrated excellent sustained antiviral activity against the test pathogen.